1994
DOI: 10.1080/07315724.1994.10718405
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of acute diarrhea with oral rehydration solutions containing glutamine.

Abstract: This study demonstrated that a glutamine-based ORS did not provide any additional therapeutic advantage over the standard WHO-ORS during treatment of dehydration in infants with acute non-cholera diarrhea.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
15
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 39 publications
(16 citation statements)
references
References 22 publications
1
15
0
Order By: Relevance
“…Three double-blind randomized controlled trials have tested the efficacy of oral Gln in the treatment of diarrheal disease in infants and children [160–162] (Table 4). Ribeiro Jr. et al [160] studied 118 infants (1–12 months of age) with acute noncholera diarrhea and dehydration and reported that Gln-based ORS did not provide additional benefit over the standard World Health Organization (WHO)-ORS with respect to diarrheal stool output, duration of diarrhea, or volume of ORS needed to achieve/maintain hydration.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Three double-blind randomized controlled trials have tested the efficacy of oral Gln in the treatment of diarrheal disease in infants and children [160–162] (Table 4). Ribeiro Jr. et al [160] studied 118 infants (1–12 months of age) with acute noncholera diarrhea and dehydration and reported that Gln-based ORS did not provide additional benefit over the standard World Health Organization (WHO)-ORS with respect to diarrheal stool output, duration of diarrhea, or volume of ORS needed to achieve/maintain hydration.…”
Section: Resultsmentioning
confidence: 99%
“…Ribeiro Jr. et al [160] studied 118 infants (1–12 months of age) with acute noncholera diarrhea and dehydration and reported that Gln-based ORS did not provide additional benefit over the standard World Health Organization (WHO)-ORS with respect to diarrheal stool output, duration of diarrhea, or volume of ORS needed to achieve/maintain hydration. This initial trial was generally of good methodological quality; however, the addition of Gln to the standard WHO-ORS led to a higher osmolality versus standard, and osmolality could affect diarrheal symptoms.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations